CANDRIAM S.C.A. – Relay Therapeutics, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$25.93M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+33.55%
quarter
Relay Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +107.85% | 601.61K shares | 16.59M | $22.37 | 1.15M |
| Q2 2022 | share | Increase | +35.59% | 146.40K shares | -2.97M | $16.75 | 557.80K |
| Q1 2022 | share | Decrease | -22.36% | -118.48K shares | -3.96M | $29.93 | 411.40K |
| Q4 2021 | share | Decrease | -5.87% | -33.05K shares | -1.47M | $31.47 | 529.88K |
| Q3 2021 | share | 0.00% | 0 shares | -2.84M | $31.53 | 562.93K | |
| Q2 2021 | share | Increase | 0.00% | 562.93K shares | 20.59M | $36.59 | 562.93K |